Medscape Diabetes & Endocrinology Editorial Board

Editorial Board — Medscape Diabetes & Endocrinology

Board Members

Harpreet S. Bajaj. MD, MPH
- Research Associate
  Leadership Sinai Center for Diabetes
  Mount Sinai Hospital
  Endocrinologist
  LMC Diabetes & Endocrinology
  Brampton, Ontario, Canada
Kenneth D. Burman, MD
- Professor
  Department of Medicine
  Georgetown University School of Medicine
  Chief
  Endocrine Section
  MedStar Washington Hospital Center
  Washington, DC
Aaron R. Chidakel, MD
- New York University Langone Medical Center
  New York, New York
Cyrus V. Desouza, MBBS
- University of Nebraska Medical Center
  Omaha, Nebraska
Vivian Fonseca, MD
- Tulane University Health Sciences Center
  New Orleans, Louisiana
Per-Henrik Groop, MD, DMSc
- University of Helsinki
  Helsinki University Hospital
  Helsinki, Finland
Simon R. Heller, MB BChir, DM, FRCP
- University of Sheffield School of Medicine
  Sheffield, South Yorkshire, United Kingdom

Akshay B. Jain, MD, FACE, CCD, ECNU, DABOM
- Wockhardt Hospital, Fraser Riner Endocrinology
  Vancouver, British Columbia, Canada
Scott Kahan, MD, MPH
- Johns Hopkins University
  George Washington University
  Washington, DC
Angela M. Leung, MD, MSc
- UCLA David Geffen School of Medicine
  Los Angeles, California
Jessica Sparks Lilley, MD
- Mississippi Center for Advanced Medicine
  Madison, Mississippi
Anne L. Peters, MD, CDE
- Keck School of Medicine
  University of Southern California
  Los Angeles, California
Arya M Sharma, MD, PhD, DSc
- University of Alberta
  Edmonton, Alberta
Dace L. Trence, MD
- University of Washington
  Seattle, Washington

Board Member Details

Harpreet S. Bajaj, MD, MPH

Research Associate, Leadership Sinai Center for Diabetes, Mount Sinai Hospital; Endocrinologist, LMC Diabetes & Endocrinology, Brampton, Ontario, Canada

Harpreet S. Bajaj, MD, MPH, had disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Diabetes Canada; LMC Healthcare
Received research grant from: Amgen; AstraZeneca; Boehringer Ingelheim; Eli Lilly and Company; Janssen; Kowa; Merck; Novo Nordisk; Public Health Agency of Canada; Sanofi; Tricida
Received income in an amount equal to or greater than $250 from: Canadian Collaborative Research Network; CPD Network; Eli Lilly and Company; Humber River Hospital; mdBriefCase; Medscape; Novo Nordisk

[ Back to Top ]

Kenneth D. Burman, MD

Professor, Department of Medicine, Georgetown University School of Medicine; Chief, Endocrine Section, MedStar Washington Hospital Center, Washington, DC

Kenneth D. Burman, MD, has disclosed the following relevant financial relationships:
Received research grant (paid to institution) from: AstraZeneca; IBSA Pharma Inc.; Exelixis

[ Back to Top ]

Aaron R. Chidakel, MD

Assistant Clinical Professor, New York University Langone Medical Center, New York, New York

Aaron R. Chidakel, MD, has disclosed no relevant financial relationships.

[ Back to Top ]

Cyrus V. Desouza, MBBS

Professor, Division Chief, Department of Internal Medicine, Division of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center, Omaha, Nebraska

Cyrus V. Desouza, MBBS, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for Novo Nordisk; Bayer

[ Back to Top ]

Vivian Fonseca, MD

Professor of Medicine and Pharmacology; Assistant Dean for Clinical Research; Tullis-Tulane Alumni Chair in Diabetes; Chief, Section of Endocrinology, Tulane University Health Sciences Center, New Orleans, Louisiana

Vivian Fonseca, MD, has disclosed the following relevant financial relationships:
Receive(d) research grant support (to Tulane) from: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim; Gilead Sciences
Received honoraria for consulting and lectures from: Takeda Pharmaceutical Company; Novo Nordisk; sanofi-aventis; Eli Lilly and Company; AstraZeneca; Abbott; Intarcia Therapeutics, Inc.; Asahi Kasei Pharma
Has stock options in: Microbiome Technologies; Mellitus Health (formally Insulin Algorithms); BRAVO4Health
Has stock in: Amgen

[ Back to Top ]

Per-Henrik Groop, MD, DMSc

Professor of Internal Medicine, University of Helsinki; Chief Physician, Division of Nephrology, Helsinki University Hospital, Helsinki, Finland

Per-Henrik Groop, MD, DMSc, has disclosed the following relevant financial relationships:
Serve(d) as a consultant and on advisory boards for: AbbVie; Astellas; AstraZeneca; Boehringer Ingelheim; Cebix; Eli Lilly; Janssen; MundiPharma; MSD; Novartis; Novo Nordisk; Sanofi
Serve(d) as a speaker for: Astellas; AstraZeneca; Boehringer Ingelheim; Eli Lilly; Elo Water; Janssen; MundiPharma; MSD; Novartis; PeerVoice; Sanofi
Received research grant from: Eli Lilly; Roche
Received income in an amount equal to or greater than $250 from: AbbVie; Astellas; AstraZeneca; Boehringer Ingelheim; Cebix; Eli Lilly; Janssen; MundiPharma; MSD; Novartis; Novo Nordisk; Sanofi; Elo Water; PeerVoice; Roche

[ Back to Top ]

Simon R. Heller, MB BChir, DM, FRCP

Professor of Clinical Diabetes, Department of Oncology and Metabolism, University of Sheffield School of Medicine; Honorary Consultant Physician, Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals Foundation Trust, Sheffield, South Yorkshire, United Kingdom

Simon R. Heller, MB BChir, DM, FRCP, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Eli Lilly and Company; Novo Nordisk; Sanofi Aventis; Zealand Pharma
Serve(d) as a speaker or member of a speakers bureau for: Novo Nordisk; AstraZeneca

[ Back to Top ]

Akshay B. Jain, MD, FACE, CCD, ECNU, DABOM

Clinical Instructor, Department of Endocrinology and Metabolism, University of British Columbia, Vancouver, Canada

Askay B. Jain, MD, FACE, CCD, ENCU, DABOM, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for: Abbott; Acerus; AstraZeneca; Boehringer-Ingelheim; Eli Lilly and Company; Janssen; Merck; Novo Nordisk
Received research grant from: Novo Nordisk

[ Back to Top ]

Scott Kahan, MD, MPH

Director, National Center for Weight and Wellness; Medical Director, S.T.O.P. Obesity Alliance, George Washington University, Washington DC; Faculty, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD

Scott Kahan, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novo Nordisk; Vivus; Gelesis

[ Back to Top ]

Angela M. Leung, MD, MSc

Associate Professor, Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, UCLA David Geffen School of Medicine; VA Greater Los Angeles Healthcare System, Los Angeles, California

Angela M. Leung, MD, MSc, has disclosed the following relevant financial relationships:
Serve(d) on the Board of Directors for: American Thyroid Association
Received income in an amount equal to or greater than $250 from: American Thyroid Association

[ Back to Top ]

Jessica Sparks Lilley, MD

Division Chief, Department of Pediatric Endocrinology, Mississippi Center for Advanced Medicine, Madison, Mississippi

Jessica Sparks Lilley, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Insulet; AbbVie

[ Back to Top ]

Anne L. Peters, MD

Professor, Department of Clinical Medicine, Keck School of Medicine; Director, University of Southern California Westside Center for Diabetes, University of Southern California, Los Angeles, California

Anne L. Peters, MD, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: Abbott Diabetes Care; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Livongo; MannKind Corporation; Medscape; Merck & Co., Inc.; Novo Nordisk; sanofi; Pendulum Therapeutics
Received research support from: Dexcom; vTvTherapeutics
Serve(d) as a member of a speakers bureau for: Novo Nordisk

[ Back to Top ]

Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC

Professor of Medicine, University of Alberta; Physician, Edmonton Bariatric Specialty Clinic, Edmonton, Alberta

Arya M Sharma, MD, PhD, DSc (h.c.), FRCPC, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Novo Nordisk; Bausch

[ Back to Top ]

Dace L. Trence, MD

Professor, Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington

Dace Trence, MD, has disclosed no relevant financial relationships.

[ Back to Top ]